Found: 20
Select item for more details and to access through your institution.
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 644, doi. 10.1007/s10637-020-01040-y
- By:
- Publication type:
- Article
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.
- Published in:
- Scientific Reports, 2015, p. 8922, doi. 10.1038/srep08922
- By:
- Publication type:
- Article
Correction: Inherited variants in genes somatically mutated in thyroid cancer.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4856, doi. 10.3390/ijms21144856
- By:
- Publication type:
- Article
Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide.
- Published in:
- Frontiers in Genetics, 2020, v. 11, p. N.PAG, doi. 10.3389/fgene.2020.00975
- By:
- Publication type:
- Article
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells.
- Published in:
- Frontiers in Genetics, 2024, p. 1, doi. 10.3389/fgene.2024.1380495
- By:
- Publication type:
- Article
The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans.
- Published in:
- Archives of Toxicology, 2018, v. 92, n. 6, p. 2137, doi. 10.1007/s00204-018-2211-2
- By:
- Publication type:
- Article
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
- Published in:
- Archives of Toxicology, 2016, v. 90, n. 12, p. 3099, doi. 10.1007/s00204-016-1660-8
- By:
- Publication type:
- Article
MicroRNA binding site polymorphisms as biomarkers in cancer management and research.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2014, v. 7, p. 173, doi. 10.2147/PGPM.S61693
- By:
- Publication type:
- Article
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Genome-wide association study on differentiated thyroid cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Inherited variants in genes somatically mutated in thyroid cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0174995
- By:
- Publication type:
- Article
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology.
- Published in:
- 3 Biotech, 2024, v. 14, n. 2, p. 1, doi. 10.1007/s13205-023-03878-4
- By:
- Publication type:
- Article
Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.
- Published in:
- Thyroid, 2021, v. 31, n. 7, p. 1056, doi. 10.1089/thy.2020.0366
- By:
- Publication type:
- Article
Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma.
- Published in:
- Thyroid, 2020, v. 30, n. 11, p. 1579, doi. 10.1089/thy.2019.0352
- By:
- Publication type:
- Article
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2527, doi. 10.3390/cancers14102527
- By:
- Publication type:
- Article
Runs of homozygosity and inbreeding in thyroid cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Obesity and the Risk of Papillary Thyroid Cancer: A Pooled Analysis of Three Case-Control Studies.
- Published in:
- Thyroid, 2014, v. 24, n. 6, p. 966, doi. 10.1089/thy.2013.0566
- By:
- Publication type:
- Article
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 12, p. 2843, doi. 10.1002/ijc.28317
- By:
- Publication type:
- Article
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma.
- Published in:
- International Journal of Cancer, 2011, v. 129, n. 12, p. 2816, doi. 10.1002/ijc.25937
- By:
- Publication type:
- Article